{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:58:22Z","timestamp":1785553102636,"version":"3.56.0"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100024990","name":"National Yang Ming Chiao Tung University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100024990","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obes Rep"],"abstract":"Abstract<\/jats:title>\n \n Purpose of Review<\/jats:title>\n Metabolic dysfunction\u2013associated steatotic liver disease (MASLD) is an increasingly prevalent complication of obesity and metabolic dysregulation, with limited therapies targeting upstream drivers of disease. Adipose tissue has emerged as a central regulator of systemic metabolic homeostasis, where dysfunction contributes to excess free fatty acid flux, chronic inflammation, and hepatic steatosis. In this context, adipose tissue browning\u2014the induction of thermogenically active beige adipocytes within white adipose depots\u2014has gained attention as a potential therapeutic mechanism.<\/jats:p>\n <\/jats:sec>\n \n Recent Findings<\/jats:title>\n Recent advances highlight that adipose browning modulates multiple pathways relevant to MASLD. These include enhanced mitochondrial \u03b2-oxidation and energy expenditure, leading to reduced lipid delivery to the liver, as well as endocrine signaling mediated by batokines such as fibroblast growth factor 21 (FGF21), irisin, and neuregulin 4 (Nrg4). Collectively, these pathways influence hepatic lipid metabolism, insulin sensitivity, and inflammatory and fibrotic processes. The preclinical studies consistently demonstrate metabolic and hepatoprotective benefits of browning; however, translational evidence in humans remains limited and heterogeneous. Factors such as reduced thermogenic capacity in obesity, inter-individual variability, and challenges in sustaining browning activation constrain clinical applicability.<\/jats:p>\n <\/jats:sec>\n \n Summary<\/jats:title>\n Overall, adipose tissue browning represents a promising component of a systems-based approach to MASLD. Future work should focus on integrating mechanistic insights with clinical investigation to clarify its therapeutic potential and to identify strategies that enable durable and patient-specific metabolic benefits.<\/jats:p>\n <\/jats:sec>","DOI":"10.1007\/s13679-026-00746-z","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:53:52Z","timestamp":1785545632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adipose Tissue Browning in MASLD and Its Molecular Mechanisms and Metabolic Crosstalk"],"prefix":"10.1007","volume":"15","author":[{"given":"Jonathan Jaime G.","family":"Guerrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Angelo S.","family":"del Rosario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo C.","family":"Encarnacion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Sung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Te","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin Israel","family":"Notarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Wen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0481-4215","authenticated-orcid":false,"given":"Wan-Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"issue":"8","key":"746_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, et al. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024;35(8):697\u2013707.","journal-title":"Trends Endocrinol Metab"},{"issue":"Suppl","key":"746_CR2","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32\u201350.","journal-title":"Clin Mol Hepatol"},{"issue":"7","key":"746_CR3","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/ueg2.70072","volume":"13","author":"P Danpanichkul","year":"2025","unstructured":"Danpanichkul P, et al. The rising global burden of MASLD and other metabolic diseases (2000\u20132021). United European Gastroenterol J. 2025;13(7):1141\u201354.","journal-title":"United European Gastroenterol J"},{"issue":"3","key":"746_CR4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/HEP.0000000000000913","volume":"83","author":"X Qi","year":"2026","unstructured":"Qi X, et al. Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease. Hepatology. 2026;83(3):661\u201378.","journal-title":"Hepatology"},{"key":"746_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155958","volume":"158","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul P, et al. Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019. Metabolism. 2024;158:155958.","journal-title":"Metabolism"},{"issue":"2","key":"746_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jhep.2024.08.011","volume":"82","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, et al. Association of food insecurity with MASLD prevalence and liver-related mortality. J Hepatol. 2025;82(2):203\u201310.","journal-title":"J Hepatol"},{"issue":"11","key":"746_CR7","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.14309\/ajg.0000000000002778","volume":"119","author":"YT Chen","year":"2024","unstructured":"Chen YT, et al. Long-term risks of cirrhosis and hepatocellular carcinoma across steatotic liver disease subtypes. Am J Gastroenterol. 2024;119(11):2241\u201350.","journal-title":"Am J Gastroenterol"},{"key":"746_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goaf018","volume":"13","author":"K Mi","year":"2025","unstructured":"Mi K, et al. Risk-stratified hepatocellular carcinoma surveillance in non-cirrhotic patients with MASLD. Gastroenterol Rep (Oxf). 2025;13:goaf018.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"16","key":"746_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164657","volume":"13","author":"C Yague-Caballero","year":"2024","unstructured":"Yague-Caballero C, et al. MASLD-related hepatocarcinoma: special features and challenges. J Clin Med. 2024;13(16):4657.","journal-title":"J Clin Med"},{"key":"746_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1411706","volume":"15","author":"M Meroni","year":"2024","unstructured":"Meroni M, Longo M, Dongiovanni P. Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin. Front Endocrinol (Lausanne). 2024;15:1411706.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"746_CR11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691\u2013702.","journal-title":"Gut"},{"key":"746_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2023.102114","volume":"83","author":"CH Cho","year":"2023","unstructured":"Cho CH, Patel S, Rajbhandari P. Adipose tissue lipid metabolism: lipolysis. Curr Opin Genet Dev. 2023;83:102114.","journal-title":"Curr Opin Genet Dev"},{"key":"746_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2252516","author":"VA Guerreiro","year":"2022","unstructured":"Guerreiro VA, Carvalho D, Freitas P. Obesity, adipose tissue, and inflammation answered in questions. J Obes. 2022. https:\/\/doi.org\/10.1155\/2022\/2252516.","journal-title":"J Obes"},{"key":"746_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111315","volume":"137","author":"B Ahmed","year":"2021","unstructured":"Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"746_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s13105-025-01117-3","volume":"81","author":"A Satheesan","year":"2025","unstructured":"Satheesan A, et al. The multifaceted regulation of white adipose tissue browning and their therapeutic potential. J Physiol Biochem. 2025;81(4):925\u201347.","journal-title":"J Physiol Biochem"},{"issue":"2","key":"746_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/ijms27020754","volume":"27","author":"K Simka-Lampa","year":"2026","unstructured":"Simka-Lampa K. Cross-talk between signaling and transcriptional networks regulating thermogenesis-insights into canonical and non-canonical regulatory pathways. Int J Mol Sci. 2026;27(2):754.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"746_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147641","volume":"23","author":"P Zhang","year":"2022","unstructured":"Zhang P, et al. Factors associated with white fat browning: new regulators of lipid metabolism. Int J Mol Sci. 2022;23(14):7641.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"746_CR18","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1113\/JP289263","volume":"603","author":"L Zhao","year":"2025","unstructured":"Zhao L, et al. Revisiting brown adipose tissue whitening: physiological mechanisms and pathophysiological consequences. J Physiol. 2025;603(19):5299\u2013326.","journal-title":"J Physiol"},{"key":"746_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.120564","volume":"411","author":"A Checa-Ros","year":"2025","unstructured":"Checa-Ros A, D\u2019Marco L. Molecular mechanisms linking adipose tissue browning to reduced cardiovascular risk. Atherosclerosis. 2025;411:120564.","journal-title":"Atherosclerosis"},{"issue":"18","key":"746_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189045","volume":"26","author":"W Jalloul","year":"2025","unstructured":"Jalloul W, et al. Functional complexity of thermogenic adipose tissue: from thermogenesis to metabolic and fibroinflammatory crosstalk. Int J Mol Sci. 2025;26(18):9045.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"746_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3390\/biomedicines13030710","volume":"13","author":"K McLeod","year":"2025","unstructured":"McLeod K, Datta V, Fuller S. Adipokines as cardioprotective factors: BAT steps up to the plate. Biomedicines. 2025;13(3):710.","journal-title":"Biomedicines"},{"issue":"2","key":"746_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/17446651.2026.2624400","volume":"21","author":"H Mirmiranpour","year":"2026","unstructured":"Mirmiranpour H, Barber TM. The role of batokines in metabolism and their therapeutic potential. Expert Rev Endocrinol Metab. 2026;21(2):143\u201351.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"746_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1592683","volume":"16","author":"D Bou Matar","year":"2025","unstructured":"Bou Matar D, et al. Adipose tissue dysfunction disrupts metabolic homeostasis: mechanisms linking fat dysregulation to disease. Front Endocrinol (Lausanne). 2025;16:1592683.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"746_CR24","doi-asserted-by":"publisher","first-page":"1003118","DOI":"10.3389\/fcell.2022.1003118","volume":"10","author":"E Borgeson","year":"2022","unstructured":"Borgeson E, Boucher J, Hagberg CE. Of mice and men: Pinpointing species differences in adipose tissue biology. Front Cell Dev Biol. 2022;10:1003118.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"746_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/cimb47050343","volume":"47","author":"MZ Dobre","year":"2025","unstructured":"Dobre MZ, Virgolici B, Timnea O. Key roles of brown, subcutaneous, and visceral adipose tissues in obesity and insulin resistance. Curr Issues Mol Biol. 2025;47(5):343.","journal-title":"Curr Issues Mol Biol"},{"key":"746_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fcvm.2017.00027","volume":"4","author":"MA Zuriaga","year":"2017","unstructured":"Zuriaga MA, et al. Humans and mice display opposing patterns of \u201cBrowning\u201d gene expression in visceral and subcutaneous white adipose tissue depots. Front Cardiovasc Med. 2017;4:27.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"746_CR27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.tcb.2022.09.008","volume":"33","author":"K Aquilano","year":"2023","unstructured":"Aquilano K, et al. Multifaceted mitochondrial quality control in brown adipose tissue. Trends Cell Biol. 2023;33(6):517\u201329.","journal-title":"Trends Cell Biol"},{"issue":"12","key":"746_CR28","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1210\/js.2019-00309","volume":"3","author":"SM Oreskovich","year":"2019","unstructured":"Oreskovich SM, et al. MRI reveals human brown adipose tissue is rapidly activated in response to cold. J Endocr Soc. 2019;3(12):2374\u201384.","journal-title":"J Endocr Soc"},{"issue":"12","key":"746_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002413","volume":"21","author":"Z Huang","year":"2023","unstructured":"Huang Z, et al. Supraclavicular brown adipocytes originate from Tbx1+ myoprogenitors. PLoS Biol. 2023;21(12):e3002413.","journal-title":"PLoS Biol"},{"issue":"2","key":"746_CR30","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","volume":"83","author":"GR Steinberg","year":"2025","unstructured":"Steinberg GR, et al. Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms. J Hepatol. 2025;83(2):584\u201395.","journal-title":"J Hepatol"},{"issue":"4","key":"746_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/biom14040483","volume":"14","author":"Y Peng","year":"2024","unstructured":"Peng Y, et al. Plasticity of adipose tissues: interconversion among white, brown, and beige fat and its role in energy homeostasis. Biomolecules. 2024;14(4):483.","journal-title":"Biomolecules"},{"issue":"3","key":"746_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/cld.1183","volume":"19","author":"CL Hanlon","year":"2022","unstructured":"Hanlon CL, Yuan L. Nonalcoholic fatty liver disease: the role of visceral adipose tissue. Clin Liver Dis (Hoboken). 2022;19(3):106\u201310.","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"18","key":"746_CR33","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.3390\/nu15183968","volume":"15","author":"I Palacios-Marin","year":"2023","unstructured":"Palacios-Marin I, et al. Adipose tissue dynamics: cellular and lipid turnover in health and disease. Nutrients. 2023;15(18):3968.","journal-title":"Nutrients"},{"issue":"1","key":"746_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2337\/diabetes.55.01.06.db05-0982","volume":"55","author":"EE Kershaw","year":"2006","unstructured":"Kershaw EE, et al. Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. Diabetes. 2006;55(1):148\u201357.","journal-title":"Diabetes"},{"key":"746_CR35","doi-asserted-by":"publisher","first-page":"1964684","DOI":"10.1155\/2022\/1964684","volume":"2022","author":"AR Althaher","year":"2022","unstructured":"Althaher AR. An overview of hormone-sensitive lipase (HSL). Sci World J. 2022;2022:1964684.","journal-title":"Sci World J"},{"issue":"8","key":"746_CR36","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1073\/pnas.051042298","volume":"98","author":"ON Ozes","year":"2001","unstructured":"Ozes ON, et al. A phosphatidylinositol 3-kinase\/Akt\/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci U S A. 2001;98(8):4640\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2\u20134","key":"746_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.vph.2012.05.003","volume":"57","author":"C Capurso","year":"2012","unstructured":"Capurso C, Capurso A. From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol. 2012;57(2\u20134):91\u20137.","journal-title":"Vascul Pharmacol"},{"issue":"7","key":"746_CR38","doi-asserted-by":"publisher","first-page":"E484","DOI":"10.1152\/ajpendo.00492.2015","volume":"310","author":"RE Patterson","year":"2016","unstructured":"Patterson RE, et al. Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity. Am J Physiol Endocrinol Metab. 2016;310(7):E484\u201394.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"19","key":"746_CR39","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.2174\/0929867324666170518101334","volume":"26","author":"L Vergani","year":"2019","unstructured":"Vergani L. Fatty acids and effects on in vitro and in vivo models of liver steatosis. Curr Med Chem. 2019;26(19):3439\u201356.","journal-title":"Curr Med Chem"},{"issue":"1","key":"746_CR40","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1038\/s41598-018-25397-6","volume":"8","author":"P Zabielski","year":"2018","unstructured":"Zabielski P, et al. The effect of high fat diet and metformin treatment on liver lipids accumulation and their impact on insulin action. Sci Rep. 2018;8(1):7249.","journal-title":"Sci Rep"},{"issue":"1","key":"746_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2018.11.002","volume":"29","author":"ET Chouchani","year":"2019","unstructured":"Chouchani ET, Kazak L, Spiegelman BM. New advances in adaptive thermogenesis: UCP1 and beyond. Cell Metab. 2019;29(1):27\u201337.","journal-title":"Cell Metab"},{"issue":"2","key":"746_CR42","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11095-022-03377-w","volume":"40","author":"RR Raj","year":"2023","unstructured":"Raj RR, Lofquist S, Lee MJ. Remodeling of adipose tissues by fatty acids: mechanistic update on browning and thermogenesis by n-3 polyunsaturated fatty acids. Pharm Res. 2023;40(2):467\u201380.","journal-title":"Pharm Res"},{"issue":"16","key":"746_CR43","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1128\/MCB.00422-15","volume":"35","author":"LM DiPilato","year":"2015","unstructured":"DiPilato LM, et al. The role of PDE3B phosphorylation in the inhibition of lipolysis by insulin. Mol Cell Biol. 2015;35(16):2752\u201360.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"746_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214606","volume":"14","author":"C Yin","year":"2019","unstructured":"Yin C, et al. PID1 alters the antilipolytic action of insulin and increases lipolysis via inhibition of AKT\/PKA pathway activation. PLoS ONE. 2019;14(4):e0214606.","journal-title":"PLoS ONE"},{"key":"746_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-physiol-060721-092939","volume":"84","author":"S Collins","year":"2022","unstructured":"Collins S. Beta-adrenergic receptors and adipose tissue metabolism: evolution of an old story. Annu Rev Physiol. 2022;84:1\u201316.","journal-title":"Annu Rev Physiol"},{"issue":"5","key":"746_CR46","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/metabo15050286","volume":"15","author":"GW Lambert","year":"2025","unstructured":"Lambert GW, Patel M, Lambert EA. The influence of the sympathetic nervous system on cardiometabolic health in response to weight gain or weight loss. Metabolites. 2025;15(5):286.","journal-title":"Metabolites"},{"issue":"4 Pt 1","key":"746_CR47","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.diabet.2008.04.001","volume":"34","author":"M Lafontan","year":"2008","unstructured":"Lafontan M, Girard J. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes Metab. 2008;34(4 Pt 1):317\u201327.","journal-title":"Diabetes Metab"},{"issue":"4","key":"746_CR48","doi-asserted-by":"publisher","first-page":"C961","DOI":"10.1152\/ajpcell.00547.2009","volume":"298","author":"MP Gaidhu","year":"2010","unstructured":"Gaidhu MP, et al. Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK. Am J Physiol Cell Physiol. 2010;298(4):C961-71.","journal-title":"Am J Physiol Cell Physiol"},{"key":"746_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-981-13-1286-1_11","volume":"1090","author":"X Li","year":"2018","unstructured":"Li X, Sun K. Regulation of lipolysis in adipose tissue and clinical significance. Adv Exp Med Biol. 2018;1090:199\u2013210.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"746_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202200264","volume":"67","author":"S Castro-Barquero","year":"2023","unstructured":"Castro-Barquero S, et al. Loss of visceral fat is associated with a reduction in inflammatory status in patients with metabolic syndrome. Mol Nutr Food Res. 2023;67(4):e2200264.","journal-title":"Mol Nutr Food Res"},{"issue":"10","key":"746_CR51","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.numecd.2014.04.017","volume":"24","author":"B Spoto","year":"2014","unstructured":"Spoto B, et al. Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity. Nutr Metab Cardiovasc Dis. 2014;24(10):1137\u201343.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"746_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/187152209788009850","volume":"9","author":"PN Black","year":"2009","unstructured":"Black PN, et al. Targeting the fatty acid transport proteins (FATP) to understand the mechanisms linking fatty acid transport to metabolism. Immunol Endocr Metab Agents Med Chem. 2009;9(1):11\u20137.","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"issue":"10","key":"746_CR53","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/PL00000621","volume":"57","author":"AK Dutta-Roy","year":"2000","unstructured":"Dutta-Roy AK. Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding\/transport proteins. Cell Mol Life Sci. 2000;57(10):1360\u201372.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"746_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12944-018-0790-9","volume":"17","author":"J Liu","year":"2018","unstructured":"Liu J, et al. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress. Lipids Health Dis. 2018;17(1):153.","journal-title":"Lipids Health Dis"},{"issue":"9","key":"746_CR55","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","volume":"11","author":"P Rada","year":"2020","unstructured":"Rada P, et al. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death Dis. 2020;11(9):802.","journal-title":"Cell Death Dis"},{"issue":"11","key":"746_CR56","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.4254\/wjh.v13.i11.1512","volume":"13","author":"Y Ma","year":"2021","unstructured":"Ma Y, et al. Fatty acid metabolism and acyl-CoA synthetases in the liver-gut axis. World J Hepatol. 2021;13(11):1512\u201333.","journal-title":"World J Hepatol"},{"issue":"4","key":"746_CR57","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2133\/dmpk.24.300","volume":"24","author":"GJ van der Vusse","year":"2009","unstructured":"van der Vusse GJ. Albumin as fatty acid transporter. Drug Metab Pharmacokinet. 2009;24(4):300\u20137.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"746_CR58","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","volume":"134","author":"J Zhou","year":"2008","unstructured":"Zhou J, et al. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology. 2008;134(2):556\u201367.","journal-title":"Gastroenterology"},{"key":"746_CR59","doi-asserted-by":"publisher","first-page":"1106544","DOI":"10.3389\/fendo.2023.1106544","volume":"14","author":"JS Chang","year":"2023","unstructured":"Chang JS. Recent insights into the molecular mechanisms of simultaneous fatty acid oxidation and synthesis in brown adipocytes. Front Endocrinol (Lausanne). 2023;14:1106544.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"746_CR60","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fphys.2015.00036","volume":"6","author":"RA Busiello","year":"2015","unstructured":"Busiello RA, Savarese S, Lombardi A. Mitochondrial uncoupling proteins and energy metabolism. Front Physiol. 2015;6:36.","journal-title":"Front Physiol"},{"issue":"6","key":"746_CR61","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tibs.2024.03.005","volume":"49","author":"SA Jones","year":"2024","unstructured":"Jones SA, et al. Structural mechanisms of mitochondrial uncoupling protein 1 regulation in thermogenesis. Trends Biochem Sci. 2024;49(6):506\u201319.","journal-title":"Trends Biochem Sci"},{"issue":"29","key":"746_CR62","doi-asserted-by":"publisher","first-page":"27077","DOI":"10.1074\/jbc.M101049200","volume":"276","author":"W Cao","year":"2001","unstructured":"Cao W, et al. beta-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase. J Biol Chem. 2001;276(29):27077\u201382.","journal-title":"J Biol Chem"},{"issue":"1","key":"746_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tem.2015.11.005","volume":"27","author":"J Chi","year":"2016","unstructured":"Chi J, Cohen P. The multifaceted roles of PRDM16: adipose biology and beyond. Trends Endocrinol Metab. 2016;27(1):11\u201323.","journal-title":"Trends Endocrinol Metab"},{"issue":"Suppl 1","key":"746_CR64","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/ijosup.2015.4","volume":"5","author":"S Kajimura","year":"2015","unstructured":"Kajimura S. Promoting brown and beige adipocyte biogenesis through the PRDM16 pathway. Int J Obes Suppl. 2015;5(Suppl 1):S11\u20134.","journal-title":"Int J Obes Suppl"},{"issue":"5","key":"746_CR65","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00005-008-0037-y","volume":"56","author":"A Zieleniak","year":"2008","unstructured":"Zieleniak A, Wojcik M, Wozniak LA. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma. Arch Immunol Ther Exp (Warsz). 2008;56(5):331\u201345.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"5","key":"746_CR66","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1194\/jlr.M011320","volume":"52","author":"T Goto","year":"2011","unstructured":"Goto T, et al. Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. J Lipid Res. 2011;52(5):873\u201384.","journal-title":"J Lipid Res"},{"issue":"2","key":"746_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00513","volume":"22","author":"M Massaro","year":"2025","unstructured":"Massaro M, et al. Nuclear respiratory factor-1 (NRF1) induction drives mitochondrial biogenesis and attenuates amyloid beta-induced mitochondrial dysfunction and neurotoxicity. Neurotherapeutics. 2025;22(2):e00513.","journal-title":"Neurotherapeutics"},{"issue":"9\u201310","key":"746_CR68","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.bbagrm.2012.03.002","volume":"1819","author":"CT Campbell","year":"2012","unstructured":"Campbell CT, Kolesar JE, Kaufman BA. Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number. Biochim Biophys Acta. 2012;1819(9\u201310):921\u20139.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"746_CR69","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbagrm.2018.12.009","volume":"1862","author":"L Moody","year":"2019","unstructured":"Moody L, et al. Epigenetic regulation of carnitine palmitoyltransferase 1 (Cpt1a) by high fat diet. Biochim Biophys Acta Gene Regul Mech. 2019;1862(2):141\u201352.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"3","key":"746_CR70","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.metabol.2014.11.009","volume":"64","author":"J Liu","year":"2015","unstructured":"Liu J, et al. The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. Metabolism. 2015;64(3):380\u201390.","journal-title":"Metabolism"},{"issue":"5","key":"746_CR71","doi-asserted-by":"publisher","first-page":"E409","DOI":"10.1152\/ajpendo.00244.2022","volume":"324","author":"A Velingkar","year":"2023","unstructured":"Velingkar A, et al. Fibroblast growth factor 21 as a potential master regulator in metabolic disorders. Am J Physiol Endocrinol Metab. 2023;324(5):E409\u201324.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"746_CR72","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/db08-0392","volume":"58","author":"J Xu","year":"2009","unstructured":"Xu J, et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes. 2009;58(1):250\u20139.","journal-title":"Diabetes"},{"issue":"2","key":"746_CR73","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41366-022-01245-6","volume":"47","author":"J Liu","year":"2023","unstructured":"Liu J, et al. The novel importance of miR-143 in obesity regulation. Int J Obes (Lond). 2023;47(2):100\u20138.","journal-title":"Int J Obes (Lond)"},{"key":"746_CR74","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13578-020-00413-3","volume":"10","author":"F Rabiee","year":"2020","unstructured":"Rabiee F, et al. New insights into the cellular activities of Fndc5\/Irisin and its signaling pathways. Cell Biosci. 2020;10:51.","journal-title":"Cell Biosci"},{"issue":"10","key":"746_CR75","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1096\/fj.201800240R","volume":"32","author":"L Hua","year":"2018","unstructured":"Hua L, et al. Identification of hepatic fibroblast growth factor 21 as a mediator in 17beta-estradiol-induced white adipose tissue browning. FASEB J. 2018;32(10):5602\u201311.","journal-title":"FASEB J"},{"issue":"8","key":"746_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600725","volume":"61","author":"A Perez-Marti","year":"2017","unstructured":"Perez-Marti A, et al. A low-protein diet induces body weight loss and browning of subcutaneous white adipose tissue through enhanced expression of hepatic fibroblast growth factor 21 (FGF21). Mol Nutr Food Res. 2017;61(8):1600725.","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"746_CR77","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jhep.2011.10.008","volume":"56","author":"J Monsenego","year":"2012","unstructured":"Monsenego J, et al. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis. J Hepatol. 2012;56(3):632\u20139.","journal-title":"J Hepatol"},{"issue":"11","key":"746_CR78","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/nm788","volume":"8","author":"T Yamauchi","year":"2002","unstructured":"Yamauchi T, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8(11):1288\u201395.","journal-title":"Nat Med"},{"issue":"1","key":"746_CR79","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4062\/biomolther.2024.188","volume":"33","author":"H An","year":"2025","unstructured":"An H, et al. New insights into AMPK, as a potential therapeutic target in metabolic dysfunction-associated steatotic liver disease and hepatic fibrosis. Biomol Ther (Seoul). 2025;33(1):18\u201338.","journal-title":"Biomol Ther (Seoul)"},{"key":"746_CR80","doi-asserted-by":"publisher","first-page":"751938","DOI":"10.3389\/fmolb.2021.751938","volume":"8","author":"YC Chen","year":"2021","unstructured":"Chen YC, et al. Therapeutic targeting of nonalcoholic fatty liver disease by downregulating SREBP-1C expression via AMPK-KLF10 axis. Front Mol Biosci. 2021;8:751938.","journal-title":"Front Mol Biosci"},{"issue":"7","key":"746_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011707","volume":"5","author":"X Kong","year":"2010","unstructured":"Kong X, et al. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS ONE. 2010;5(7):e11707.","journal-title":"PLoS ONE"},{"issue":"10","key":"746_CR82","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/oby.2012.32","volume":"20","author":"MP Valdecantos","year":"2012","unstructured":"Valdecantos MP, et al. Lipoic acid improves mitochondrial function in nonalcoholic steatosis through the stimulation of sirtuin 1 and sirtuin 3. Obesity (Silver Spring). 2012;20(10):1974\u201383.","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"746_CR83","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10059-013-0138-2","volume":"35","author":"SG Kim","year":"2013","unstructured":"Kim SG, Buel GR, Blenis J. Nutrient regulation of the mTOR complex 1 signaling pathway. Mol Cells. 2013;35(6):463\u201373.","journal-title":"Mol Cells"},{"issue":"2","key":"746_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117000","volume":"10","author":"HL Kenerson","year":"2015","unstructured":"Kenerson HL, et al. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt. PLoS ONE. 2015;10(2):e0117000.","journal-title":"PLoS ONE"},{"issue":"1","key":"746_CR85","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","volume":"21","author":"D Zhang","year":"2023","unstructured":"Zhang D, et al. Short-chain fatty acids in diseases. Cell Commun Signal. 2023;21(1):212.","journal-title":"Cell Commun Signal"},{"issue":"11","key":"746_CR86","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1096\/fj.201500030R","volume":"30","author":"A Veprik","year":"2016","unstructured":"Veprik A, et al. GPR41 modulates insulin secretion and gene expression in pancreatic beta-cells and modifies metabolic homeostasis in fed and fasting states. FASEB J. 2016;30(11):3860\u20139.","journal-title":"FASEB J"},{"issue":"9","key":"746_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094240","volume":"26","author":"X Lin","year":"2025","unstructured":"Lin X, et al. Crosstalk between bile acids and intestinal epithelium: multidimensional roles of farnesoid X receptor and Takeda G protein receptor 5. Int J Mol Sci. 2025;26(9):4240.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"746_CR88","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.3390\/metabo12070647","volume":"12","author":"H Mori","year":"2022","unstructured":"Mori H, et al. Farnesoid X receptor, bile acid metabolism, and gut microbiota. Metabolites. 2022;12(7):S21\u20136.","journal-title":"Metabolites"},{"issue":"4","key":"746_CR89","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.29857","volume":"68","author":"P Pathak","year":"2018","unstructured":"Pathak P, et al. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology. 2018;68(4):1574\u201388.","journal-title":"Hepatology"},{"issue":"3","key":"746_CR90","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"JYL Chiang","year":"2020","unstructured":"Chiang JYL, Ferrell JM. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol. 2020;318(3):G554\u201373.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"746_CR91","doi-asserted-by":"publisher","first-page":"1667037","DOI":"10.3389\/fendo.2025.1667037","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Chu H, Yang L. White adipose tissue browning and peroxisome proliferator activated receptors in MASLD. Front Endocrinol (Lausanne). 2025;16:1667037.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"746_CR92","doi-asserted-by":"publisher","first-page":"8402","DOI":"10.1038\/s41467-024-52622-w","volume":"15","author":"E Erdil","year":"2024","unstructured":"Erdil E, et al. Predicting standardized uptake value of brown adipose tissue from CT scans using convolutional neural networks. Nat Commun. 2024;15(1):8402.","journal-title":"Nat Commun"},{"issue":"11","key":"746_CR93","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.3390\/cells10113030","volume":"10","author":"R Singh","year":"2021","unstructured":"Singh R, et al. Human brown adipose tissue and metabolic health: potential for therapeutic avenues. Cells. 2021;10(11):3030.","journal-title":"Cells"},{"issue":"7","key":"746_CR94","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.2337\/db10-0004","volume":"59","author":"C Pfannenberg","year":"2010","unstructured":"Pfannenberg C, et al. Impact of age on the relationships of brown adipose tissue with sex and adiposity in humans. Diabetes. 2010;59(7):1789\u201393.","journal-title":"Diabetes"},{"key":"746_CR95","first-page":"210475","volume":"18","author":"CT Herz","year":"2021","unstructured":"Herz CT, et al. Active brown adipose tissue is associated with a healthier metabolic phenotype in obesity. Diabetes. 2021;18:210475.","journal-title":"Diabetes"},{"issue":"18","key":"746_CR96","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1042\/CS20257571","volume":"139","author":"WH Lee","year":"2025","unstructured":"Lee WH, et al. The physiology of MASLD: molecular pathways between liver and adipose tissues. Clin Sci (Lond). 2025;139(18):1015\u201346.","journal-title":"Clin Sci (Lond)"},{"issue":"9","key":"746_CR97","doi-asserted-by":"publisher","first-page":"113221","DOI":"10.1016\/j.isci.2025.113221","volume":"28","author":"CMP Martin","year":"2025","unstructured":"Martin CMP, et al. Thermoneutral housing worsens MASLD and reveals defective brown adipose tissue response to beta3-adrenergic stimulation. iScience. 2025;28(9):113221.","journal-title":"iScience"},{"key":"746_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/jpps.2024.13157","volume":"27","author":"B Prapaharan","year":"2024","unstructured":"Prapaharan B, Lea M, Beaudry JL. Weighing in on the role of brown adipose tissue for treatment of obesity. J Pharm Pharm Sci. 2024;27:13157.","journal-title":"J Pharm Pharm Sci"},{"issue":"2","key":"746_CR99","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1210\/endrev\/bnac015","volume":"44","author":"AC Carpentier","year":"2023","unstructured":"Carpentier AC, et al. Brown adipose tissue-a translational perspective. Endocr Rev. 2023;44(2):143\u201392.","journal-title":"Endocr Rev"},{"issue":"1","key":"746_CR100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cmet.2024.11.002","volume":"37","author":"AM Cypess","year":"2025","unstructured":"Cypess AM, et al. Emerging debates and resolutions in brown adipose tissue research. Cell Metab. 2025;37(1):12\u201333.","journal-title":"Cell Metab"},{"key":"746_CR101","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3389\/fendo.2020.00633","volume":"11","author":"R Pan","year":"2020","unstructured":"Pan R, et al. Metabolic improvement via enhancing thermogenic fat-mediated non-shivering thermogenesis: from rodents to humans. Front Endocrinol (Lausanne). 2020;11:633.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"746_CR102","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s13238-017-0378-6","volume":"8","author":"X Liu","year":"2017","unstructured":"Liu X, Cervantes C, Liu F. Common and distinct regulation of human and mouse brown and beige adipose tissues: a promising therapeutic target for obesity. Protein Cell. 2017;8(6):446\u201354.","journal-title":"Protein Cell"},{"issue":"4","key":"746_CR103","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41366-019-0471-4","volume":"44","author":"E Sanchez-Rangel","year":"2020","unstructured":"Sanchez-Rangel E, et al. Norepinephrine transporter availability in brown fat is reduced in obesity: a human PET study with [(11)C] MRB. Int J Obes (Lond). 2020;44(4):964\u20137.","journal-title":"Int J Obes (Lond)"},{"issue":"11","key":"746_CR104","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/jamacardio.2023.3003","volume":"8","author":"JL Balligand","year":"2023","unstructured":"Balligand JL, et al. Repurposing the beta3-adrenergic receptor agonist mirabegron in patients with structural cardiac disease: the Beta3-LVH phase 2b randomized clinical trial. JAMA Cardiol. 2023;8(11):1031\u201340.","journal-title":"JAMA Cardiol"},{"issue":"21","key":"746_CR105","doi-asserted-by":"publisher","first-page":"6897","DOI":"10.3390\/jcm12216897","volume":"12","author":"AM Dabrowska","year":"2023","unstructured":"Dabrowska AM, Dudka J. Mirabegron, a selective beta3-adrenergic receptor agonist, as a potential anti-obesity drug. J Clin Med. 2023;12(21):6897.","journal-title":"J Clin Med"},{"issue":"5","key":"746_CR106","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1172\/JCI131126","volume":"130","author":"AE O'Mara","year":"2020","unstructured":"O\u2019Mara AE, et al. Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J Clin Invest. 2020;130(5):2209\u201319.","journal-title":"J Clin Invest"},{"issue":"6","key":"746_CR107","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/cr.2013.64","volume":"23","author":"X Liu","year":"2013","unstructured":"Liu X, et al. Brown adipose tissue transplantation improves whole-body energy metabolism. Cell Res. 2013;23(6):851\u20134.","journal-title":"Cell Res"},{"issue":"11","key":"746_CR108","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/cells8111339","volume":"8","author":"D Pinheiro","year":"2019","unstructured":"Pinheiro D, et al. Mechanisms underlying cell therapy in liver fibrosis: an overview. Cells. 2019;8(11):1339.","journal-title":"Cells"},{"issue":"20","key":"746_CR109","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.3390\/ijms20205058","volume":"20","author":"F Lizcano","year":"2019","unstructured":"Lizcano F. The beige adipocyte as a therapy for metabolic diseases. Int J Mol Sci. 2019;20(20):5058.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"746_CR110","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40139-015-0094-y","volume":"3","author":"PH Park","year":"2015","unstructured":"Park PH, Sanz-Garcia C, Nagy LE. Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver. Curr Pathobiol Rep. 2015;3(4):243\u201352.","journal-title":"Curr Pathobiol Rep"},{"issue":"8","key":"746_CR111","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1530\/EC-20-0152","volume":"9","author":"H Keinicke","year":"2020","unstructured":"Keinicke H, et al. FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation. Endocr Connect. 2020;9(8):755\u201368.","journal-title":"Endocr Connect"},{"key":"746_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/biology11111657","author":"L Ma","year":"2022","unstructured":"Ma L, et al. MicroRNAs as mediators of adipose thermogenesis and potential therapeutic targets for obesity. Biology (Basel). 2022. https:\/\/doi.org\/10.3390\/biology11111657.","journal-title":"Biology (Basel)"},{"issue":"10504","key":"746_CR113","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0140-6736(25)01073-6","volume":"406","author":"M Noureddin","year":"2025","unstructured":"Noureddin M, et al. Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial. Lancet. 2025;406(10504):719\u201330.","journal-title":"Lancet"},{"issue":"7","key":"746_CR114","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41591-021-01425-3","volume":"27","author":"SA Harrison","year":"2021","unstructured":"Harrison SA, et al. Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial. Nat Med. 2021;27(7):1262\u201371.","journal-title":"Nat Med"},{"key":"746_CR115","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S560034","volume":"20","author":"K Rama","year":"2026","unstructured":"Rama K, Jahagirdar V, Sanyal AJ. Fibroblast growth factor 21: mechanisms, therapeutic potential, and clinical translation in metabolic dysfunction. Drug Des Devel Ther. 2026;20:560034.","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"746_CR116","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00228-023-03614-0","volume":"80","author":"L Ma","year":"2024","unstructured":"Ma L, Xiong L, Huang G. Effects of mirabegron on brown adipose tissue and metabolism in humans: A systematic review and meta-analysis. Eur J Clin Pharmacol. 2024;80(3):317\u201333.","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"746_CR117","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41579-025-01183-w","volume":"23","author":"I Mukhopadhya","year":"2025","unstructured":"Mukhopadhya I, Louis P. Gut microbiota-derived short-chain fatty acids and their role in human health and disease. Nat Rev Microbiol. 2025;23(10):635\u201351.","journal-title":"Nat Rev Microbiol"},{"issue":"15","key":"746_CR118","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1093\/cvr\/cvae228","volume":"120","author":"RR Muralitharan","year":"2024","unstructured":"Muralitharan RR, Buikema JW, Marques FZ. Minimizing gut microbiome confounding factors in cardiovascular research. Cardiovasc Res. 2024;120(15):e60\u20132.","journal-title":"Cardiovasc Res"},{"key":"746_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1197759","volume":"17","author":"V Mansuy-Aubert","year":"2023","unstructured":"Mansuy-Aubert V, Ravussin Y. Short chain fatty acids: the messengers from down below. Front Neurosci. 2023;17:1197759.","journal-title":"Front Neurosci"},{"issue":"1","key":"746_CR120","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41591-020-1126-7","volume":"27","author":"T Becher","year":"2021","unstructured":"Becher T, et al. Brown adipose tissue is associated with cardiometabolic health. Nat Med. 2021;27(1):58\u201365.","journal-title":"Nat Med"},{"issue":"12","key":"746_CR121","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.2337\/db14-0746","volume":"63","author":"M Chondronikola","year":"2014","unstructured":"Chondronikola M, et al. Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes. 2014;63(12):4089\u201399.","journal-title":"Diabetes"},{"issue":"6","key":"746_CR122","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.cmet.2016.04.029","volume":"23","author":"M Chondronikola","year":"2016","unstructured":"Chondronikola M, et al. Brown adipose tissue activation is linked to distinct systemic effects on lipid metabolism in humans. Cell Metab. 2016;23(6):1200\u20136.","journal-title":"Cell Metab"},{"issue":"11","key":"746_CR123","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1111\/dom.14120","volume":"22","author":"KJ Nahon","year":"2020","unstructured":"Nahon KJ, et al. The effect of mirabegron on energy expenditure and brown adipose tissue in healthy lean South Asian and Europid men. Diabetes Obes Metab. 2020;22(11):2032\u201344.","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"746_CR124","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1210\/clinem\/dgae016","volume":"109","author":"ME Walker","year":"2024","unstructured":"Walker ME, et al. Brown adipose tissue activation in humans increases plasma levels of lipid mediators. J Clin Endocrinol Metab. 2024;109(7):1837\u201349.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"746_CR125","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/biomedicines12030537","volume":"12","author":"S Tabei","year":"2024","unstructured":"Tabei S, et al. Metabolic effects of brown adipose tissue activity due to cold exposure in humans: a systematic review and meta-analysis of RCTs and non-RCTs. Biomedicines. 2024;12(3):753.","journal-title":"Biomedicines"},{"key":"746_CR126","doi-asserted-by":"publisher","first-page":"1037458","DOI":"10.3389\/fendo.2022.1037458","volume":"13","author":"LC Perez","year":"2022","unstructured":"Perez LC, et al. Interventions associated with brown adipose tissue activation and the impact on energy expenditure and weight loss: a systematic review. Front Endocrinol (Lausanne). 2022;13:1037458.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"746_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2025.1645475","volume":"16","author":"F Gorini Pereira","year":"2025","unstructured":"Gorini Pereira F, et al. The thermogenic effect of mirabegron ingestion during cool conditions. Front Physiol. 2025;16:1645475.","journal-title":"Front Physiol"},{"issue":"6","key":"746_CR128","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2015.05.018","volume":"21","author":"P Lee","year":"2015","unstructured":"Lee P, Swarbrick MM, Greenfield JR. The sum of all browning in FGF21 therapeutics. Cell Metab. 2015;21(6):795\u20136.","journal-title":"Cell Metab"},{"issue":"1","key":"746_CR129","doi-asserted-by":"publisher","first-page":"66","DOI":"10.7150\/ijbs.73936","volume":"19","author":"H Tan","year":"2023","unstructured":"Tan H, et al. Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine. Int J Biol Sci. 2023;19(1):66\u201388.","journal-title":"Int J Biol Sci"},{"key":"746_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/cimb48020201","author":"ZD Yang","year":"2026","unstructured":"Yang ZD, et al. Diet-induced browning of white adipose tissue: molecular targets, mechanisms, and therapeutic potential. Curr Issues Mol Biol. 2026. https:\/\/doi.org\/10.3390\/cimb48020201.","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"746_CR131","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41374-018-0120-x","volume":"99","author":"L Poekes","year":"2019","unstructured":"Poekes L, et al. Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitis. Lab Invest. 2019;99(1):4\u201316.","journal-title":"Lab Invest"},{"key":"746_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27031321","author":"YA Bae","year":"2026","unstructured":"Bae YA, Cheon HG. Adipocyte browning: a promising avenue in anti-obesity therapy. Int J Mol Sci. 2026. https:\/\/doi.org\/10.3390\/ijms27031321.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"746_CR133","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1172\/JCI78362","volume":"125","author":"L Sidossis","year":"2015","unstructured":"Sidossis L, Kajimura S. Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis. J Clin Invest. 2015;125(2):478\u201386.","journal-title":"J Clin Invest"},{"issue":"1","key":"746_CR134","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cmet.2014.12.009","volume":"21","author":"AM Cypess","year":"2015","unstructured":"Cypess AM, et al. Activation of human brown adipose tissue by a beta3-adrenergic receptor agonist. Cell Metab. 2015;21(1):33\u20138.","journal-title":"Cell Metab"},{"issue":"42","key":"746_CR135","doi-asserted-by":"publisher","first-page":"e2407789","DOI":"10.1002\/advs.202407789","volume":"11","author":"X Zhu","year":"2024","unstructured":"Zhu X, et al. Intermittent fasting-induced Orm2 promotes adipose browning via the GP130\/IL23R-p38 cascade. Adv Sci (Weinh). 2024;11(42):e2407789.","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"746_CR136","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrm.2016.96","volume":"17","author":"W Wang","year":"2016","unstructured":"Wang W, Seale P. Control of brown and beige fat development. Nat Rev Mol Cell Biol. 2016;17(11):691\u2013702.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"746_CR137","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/nm.3361","volume":"19","author":"M Harms","year":"2013","unstructured":"Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med. 2013;19(10):1252\u201363.","journal-title":"Nat Med"},{"issue":"8","key":"746_CR138","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nrm.2016.62","volume":"17","author":"T Inagaki","year":"2016","unstructured":"Inagaki T, Sakai J, Kajimura S. Transcriptional and epigenetic control of brown and beige adipose cell fate and function. Nat Rev Mol Cell Biol. 2016;17(8):480\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"746_CR139","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nm.2297","volume":"17","author":"A Bartelt","year":"2011","unstructured":"Bartelt A, et al. Brown adipose tissue activity controls triglyceride clearance. Nat Med. 2011;17(2):200\u20135.","journal-title":"Nat Med"},{"issue":"1","key":"746_CR140","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jcp.25450","volume":"232","author":"N Jeremic","year":"2017","unstructured":"Jeremic N, Chaturvedi P, Tyagi SC. Browning of white fat: novel insight into factors, mechanisms, and therapeutics. J Cell Physiol. 2017;232(1):61\u20138.","journal-title":"J Cell Physiol"},{"issue":"5","key":"746_CR141","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1172\/JCI134892","volume":"130","author":"BS Finlin","year":"2020","unstructured":"Finlin BS, et al. The beta3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans. J Clin Invest. 2020;130(5):2319\u201331.","journal-title":"J Clin Invest"},{"issue":"6","key":"746_CR142","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115(6):1627\u201335.","journal-title":"J Clin Invest"},{"issue":"9","key":"746_CR143","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1074\/jbc.M109.088708","volume":"285","author":"K Ohashi","year":"2010","unstructured":"Ohashi K, et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem. 2010;285(9):6153\u201360.","journal-title":"J Biol Chem"},{"issue":"1","key":"746_CR144","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1172\/JCI62308","volume":"123","author":"KI Stanford","year":"2013","unstructured":"Stanford KI, et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J Clin Invest. 2013;123(1):215\u201323.","journal-title":"J Clin Invest"},{"issue":"3","key":"746_CR145","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1101\/gad.177857.111","volume":"26","author":"FM Fisher","year":"2012","unstructured":"Fisher FM, et al. FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012;26(3):271\u201381.","journal-title":"Genes Dev"},{"issue":"5","key":"746_CR146","doi-asserted-by":"publisher","first-page":"e63517","DOI":"10.1371\/journal.pone.0063517","volume":"8","author":"KH Kim","year":"2013","unstructured":"Kim KH, et al. Acute exercise induces FGF21 expression in mice and in healthy humans. PLoS ONE. 2013;8(5):e63517.","journal-title":"PLoS ONE"},{"issue":"2","key":"746_CR147","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","volume":"20","author":"C Canto","year":"2009","unstructured":"Canto C, Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol. 2009;20(2):98\u2013105.","journal-title":"Curr Opin Lipidol"},{"issue":"5","key":"746_CR148","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852\u201371.","journal-title":"Cell"},{"issue":"5","key":"746_CR149","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s42255-021-00389-5","volume":"3","author":"EL Mills","year":"2021","unstructured":"Mills EL, et al. UCP1 governs liver extracellular succinate and inflammatory pathogenesis. Nat Metab. 2021;3(5):604\u201317.","journal-title":"Nat Metab"},{"issue":"4","key":"746_CR150","first-page":"3121","volume":"16","author":"T Shen","year":"2018","unstructured":"Shen T, et al. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1\/AMPKalpha pathway. Exp Ther Med. 2018;16(4):3121\u20138.","journal-title":"Exp Ther Med"},{"key":"746_CR151","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1038\/ncomms7356","volume":"6","author":"JF Berbee","year":"2015","unstructured":"Berbee JF, et al. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat Commun. 2015;6:6356.","journal-title":"Nat Commun"},{"issue":"1","key":"746_CR152","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1194\/jlr.M052746","volume":"56","author":"PP Khedoe","year":"2015","unstructured":"Khedoe PP, et al. Brown adipose tissue takes up plasma triglycerides mostly after lipolysis. J Lipid Res. 2015;56(1):51\u20139.","journal-title":"J Lipid Res"},{"issue":"1","key":"746_CR153","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrendo.2013.204","volume":"10","author":"A Bartelt","year":"2014","unstructured":"Bartelt A, Heeren J. Adipose tissue browning and metabolic health. Nat Rev Endocrinol. 2014;10(1):24\u201336.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"746_CR154","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1161\/CIRCRESAHA.115.306647","volume":"118","author":"G Hoeke","year":"2016","unstructured":"Hoeke G, et al. Role of brown fat in lipoprotein metabolism and atherosclerosis. Circ Res. 2016;118(1):173\u201382.","journal-title":"Circ Res"},{"issue":"19","key":"746_CR155","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.18632\/aging.204318","volume":"14","author":"W In Het Panhuis","year":"2022","unstructured":"In Het Panhuis W, et al. Aging attenuates diurnal lipid uptake by brown adipose tissue. Aging (Albany NY). 2022;14(19):7734\u201351.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"746_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101370","volume":"5","author":"M Chondronikola","year":"2024","unstructured":"Chondronikola M, et al. Very-low-density lipoprotein triglyceride and free fatty acid plasma kinetics in women with high or low brown adipose tissue volume and overweight\/obesity. Cell Rep Med. 2024;5(1):101370.","journal-title":"Cell Rep Med"},{"issue":"7832","key":"746_CR157","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41586-020-2856-x","volume":"587","author":"W Sun","year":"2020","unstructured":"Sun W, et al. SnRNA-seq reveals a subpopulation of adipocytes that regulates thermogenesis. Nature. 2020;587(7832):98\u2013102.","journal-title":"Nature"},{"issue":"2","key":"746_CR158","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3748\/wjg.v24.i2.195","volume":"24","author":"JD Roth","year":"2018","unstructured":"Roth JD, et al. INT-767 improves histopathological features in a diet-induced ob\/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis. World J Gastroenterol. 2018;24(2):195\u2013210.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"746_CR159","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14321","volume":"23","author":"D Natarajan","year":"2024","unstructured":"Natarajan D, et al. Chronic beta3-AR stimulation activates distinct thermogenic mechanisms in brown and white adipose tissue and improves systemic metabolism in aged mice. Aging Cell. 2024;23(12):e14321.","journal-title":"Aging Cell"},{"issue":"6","key":"746_CR160","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2337\/db20-1073","volume":"70","author":"J Ryu","year":"2021","unstructured":"Ryu J, et al. Adiponectin alleviates diet-induced inflammation in the liver by suppressing MCP-1 expression and macrophage infiltration. Diabetes. 2021;70(6):1303\u201316.","journal-title":"Diabetes"},{"issue":"4","key":"746_CR161","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/hep.22444","volume":"48","author":"M Zhou","year":"2008","unstructured":"Zhou M, et al. Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury. Hepatology. 2008;48(4):1087\u201396.","journal-title":"Hepatology"},{"key":"746_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.908749","volume":"13","author":"W Liang","year":"2022","unstructured":"Liang W, et al. The roles of adipose tissue macrophages in human disease. Front Immunol. 2022;13:908749.","journal-title":"Front Immunol"},{"key":"746_CR163","doi-asserted-by":"publisher","first-page":"1394030","DOI":"10.3389\/fphys.2024.1394030","volume":"15","author":"A Lukawska","year":"2024","unstructured":"Lukawska A, Mulak A. A correlation of serum fibroblast growth factor 21 level with inflammatory markers and indicators of nutritional status in patients with inflammatory bowel disease. Front Physiol. 2024;15:1394030.","journal-title":"Front Physiol"},{"key":"746_CR164","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fendo.2020.00156","volume":"11","author":"F Omran","year":"2020","unstructured":"Omran F, Christian M. Inflammatory signaling and brown fat activity. Front Endocrinol (Lausanne). 2020;11:156.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"746_CR165","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/cells13090756","volume":"13","author":"B Gupta","year":"2024","unstructured":"Gupta B, et al. Selective targeting of alpha(4)beta(7)\/MAdCAM-1 axis suppresses fibrosis progression by reducing proinflammatory T cell recruitment to the liver. Cells. 2024;13(9):756.","journal-title":"Cells"},{"issue":"1","key":"746_CR166","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1158\/1940-6207.CAPR-20-0181","volume":"14","author":"C Duggan","year":"2021","unstructured":"Duggan C, et al. Changes in dietary inflammatory index patterns with weight loss in women: a randomized controlled trial. Cancer Prev Res (Phila). 2021;14(1):85\u201394.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"14","key":"746_CR167","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","volume":"289","author":"K Esposito","year":"2003","unstructured":"Esposito K, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289(14):1799\u2013804.","journal-title":"JAMA"},{"issue":"3","key":"746_CR168","doi-asserted-by":"publisher","first-page":"e14718","DOI":"10.14814\/phy2.14718","volume":"9","author":"JRH Raiko","year":"2021","unstructured":"Raiko JRH, et al. Changes in electrocardiogram parameters during acute nonshivering cold exposure and associations with brown adipose tissue activity, plasma catecholamine levels, and brachial blood pressure in healthy adults. Physiol Rep. 2021;9(3):e14718.","journal-title":"Physiol Rep"},{"issue":"1","key":"746_CR169","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40101-020-00226-w","volume":"39","author":"H Taniguchi","year":"2020","unstructured":"Taniguchi H, et al. Effects of beta-conglycinin intake on circulating FGF21 levels and brown adipose tissue activity in Japanese young men: a single intake study and a randomized controlled trial. J Physiol Anthropol. 2020;39(1):17.","journal-title":"J Physiol Anthropol"},{"issue":"17","key":"746_CR170","doi-asserted-by":"publisher","first-page":"9001","DOI":"10.7150\/thno.111643","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, et al. Imaging brown adipose tissue: current state and future perspective. Theranostics. 2025;15(17):9001\u201318.","journal-title":"Theranostics"},{"issue":"5","key":"746_CR171","doi-asserted-by":"publisher","first-page":"R229","DOI":"10.1186\/ar4070","volume":"14","author":"F Fang","year":"2012","unstructured":"Fang F, et al. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy. Arthritis Res Ther. 2012;14(5):R229.","journal-title":"Arthritis Res Ther"},{"key":"746_CR172","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.taap.2015.11.012","volume":"290","author":"P Xu","year":"2016","unstructured":"Xu P, et al. Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-beta\/smad2\/3 and NF-kappaB signaling pathways. Toxicol Appl Pharmacol. 2016;290:43\u201353.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"746_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102530","volume":"298","author":"XX Wang","year":"2022","unstructured":"Wang XX, et al. The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice. J Biol Chem. 2022;298(11):102530.","journal-title":"J Biol Chem"},{"issue":"5","key":"746_CR174","doi-asserted-by":"publisher","first-page":"2100864","DOI":"10.1183\/13993003.00864-2021","volume":"59","author":"S Song","year":"2022","unstructured":"Song S, et al. Intracellular hydroxyproline imprinting following resolution of bleomycin-induced pulmonary fibrosis. Eur Respir J. 2022;59(5):2100864.","journal-title":"Eur Respir J"},{"issue":"4","key":"746_CR175","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cmet.2017.03.005","volume":"25","author":"LD BonDurant","year":"2017","unstructured":"BonDurant LD, et al. FGF21 regulates metabolism through adipose-dependent and -independent mechanisms. Cell Metab. 2017;25(4):935-944 e4.","journal-title":"Cell Metab"},{"issue":"12","key":"746_CR176","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/nm.3713","volume":"20","author":"GX Wang","year":"2014","unstructured":"Wang GX, et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat Med. 2014;20(12):1436\u201343.","journal-title":"Nat Med"},{"issue":"1","key":"746_CR177","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12876-025-04097-2","volume":"25","author":"MA Tapak","year":"2025","unstructured":"Tapak MA, Glolan SR, Moradi Y. The impact of serum neuregulin 4 (NRG-4) levels on non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis. BMC Gastroenterol. 2025;25(1):509.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"746_CR178","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/CM9.0000000000003427","volume":"139","author":"Y Zhao","year":"2026","unstructured":"Zhao Y, et al. Irisin alleviates hepatic steatosis by activating the autophagic SIRT3 pathway. Chin Med J (Engl). 2026;139(3):443\u201356.","journal-title":"Chin Med J (Engl)"},{"issue":"16","key":"746_CR179","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.3390\/ijms23169448","volume":"23","author":"PC Chan","year":"2022","unstructured":"Chan PC, Hsieh PS. The role and regulatory mechanism of brown adipose tissue activation in diet-induced thermogenesis in health and diseases. Int J Mol Sci. 2022;23(16):9448.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"746_CR180","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.32449","volume":"77","author":"C Hu","year":"2023","unstructured":"Hu C, et al. Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC. Hepatology. 2023;77(1):48\u201364.","journal-title":"Hepatology"},{"issue":"16","key":"746_CR181","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.143451","volume":"6","author":"A Abdullahi","year":"2021","unstructured":"Abdullahi A, et al. Adipose browning response to burn trauma is impaired with aging. JCI Insight. 2021;6(16):e143451.","journal-title":"JCI Insight"},{"issue":"4","key":"746_CR182","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/2231-4040.90879","volume":"2","author":"S Tyagi","year":"2011","unstructured":"Tyagi S, et al. The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J Adv Pharm Technol Res. 2011;2(4):236\u201340.","journal-title":"J Adv Pharm Technol Res"},{"issue":"4","key":"746_CR183","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/cbf.3111","volume":"33","author":"TL Rachid","year":"2015","unstructured":"Rachid TL, et al. PPAR-alpha agonist elicits metabolically active brown adipocytes and weight loss in diet-induced obese mice. Cell Biochem Funct. 2015;33(4):249\u201356.","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"746_CR184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191365","volume":"13","author":"TL Rachid","year":"2018","unstructured":"Rachid TL, et al. Differential actions of PPAR-alpha and PPAR-beta\/delta on beige adipocyte formation: a study in the subcutaneous white adipose tissue of obese male mice. PLoS ONE. 2018;13(1):e0191365.","journal-title":"PLoS ONE"},{"key":"746_CR185","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fphys.2019.00037","volume":"10","author":"D Cuevas-Ramos","year":"2019","unstructured":"Cuevas-Ramos D, Mehta R, Aguilar-Salinas CA. Fibroblast growth factor 21 and browning of white adipose tissue. Front Physiol. 2019;10:37.","journal-title":"Front Physiol"},{"issue":"1","key":"746_CR186","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1038\/s41467-022-29499-8","volume":"13","author":"CM Hill","year":"2022","unstructured":"Hill CM, et al. FGF21 is required for protein restriction to extend lifespan and improve metabolic health in male mice. Nat Commun. 2022;13(1):1897.","journal-title":"Nat Commun"},{"issue":"5","key":"746_CR187","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3892\/ijmm.2026.5795","volume":"57","author":"X Yang","year":"2026","unstructured":"Yang X, et al. m(6)A in adipose tissue inflammation: a novel regulator of obesity and metabolic diseases (review). Int J Mol Med. 2026;57(5):124.","journal-title":"Int J Mol Med"},{"issue":"407","key":"746_CR188","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aab3357","volume":"8","author":"CY Wang","year":"2015","unstructured":"Wang CY, et al. Loss of FTO in adipose tissue decreases Angptl4 translation and alters triglyceride metabolism. Sci Signal. 2015;8(407):ra127.","journal-title":"Sci Signal"},{"issue":"11","key":"746_CR189","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202052348","volume":"22","author":"R Wu","year":"2021","unstructured":"Wu R, et al. m6A methylation promotes white-to-beige fat transition by facilitating Hif1a translation. EMBO Rep. 2021;22(11):e52348.","journal-title":"EMBO Rep"},{"key":"746_CR190","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fendo.2017.00205","volume":"8","author":"F Shamsi","year":"2017","unstructured":"Shamsi F, Zhang H, Tseng YH. MicroRNA regulation of brown adipogenesis and thermogenic energy expenditure. Front Endocrinol (Lausanne). 2017;8:205.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"746_CR191","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/ijms26020782","volume":"26","author":"S Tomasini","year":"2025","unstructured":"Tomasini S, et al. The role of microRNA-22 in metabolism. Int J Mol Sci. 2025;26(2):784.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"746_CR192","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612870","volume":"24","author":"R Panella","year":"2023","unstructured":"Panella R, et al. MicroRNA-22 is a key regulator of lipid and metabolic homeostasis. Int J Mol Sci. 2023;24(16):12870.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"746_CR193","doi-asserted-by":"publisher","first-page":"12308","DOI":"10.1096\/fj.201903283RR","volume":"34","author":"XF Man","year":"2020","unstructured":"Man XF, et al. Insulin receptor substrate-1 inhibits high-fat diet-induced obesity by browning of white adipose tissue through miR-503. FASEB J. 2020;34(9):12308\u201323.","journal-title":"FASEB J"},{"issue":"17","key":"746_CR194","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401464R","volume":"38","author":"N Ma","year":"2024","unstructured":"Ma N, et al. MicroRNAs in metabolic dysfunction-associated diseases: pathogenesis and therapeutic opportunities. FASEB J. 2024;38(17):e70038.","journal-title":"FASEB J"},{"issue":"12","key":"746_CR195","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.3390\/cells10123342","volume":"10","author":"A Kurylowicz","year":"2021","unstructured":"Kurylowicz A. MicroRNAs in human adipose tissue physiology and dysfunction. Cells. 2021;10(12):3342.","journal-title":"Cells"},{"key":"746_CR196","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1426551","volume":"11","author":"SP Mambrini","year":"2024","unstructured":"Mambrini SP, et al. Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility. Front Nutr. 2024;11:1426551.","journal-title":"Front Nutr"},{"issue":"21","key":"746_CR197","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111512","volume":"22","author":"WJ Mu","year":"2021","unstructured":"Mu WJ, et al. Exercise-mediated browning of white adipose tissue: its significance, mechanism and effectiveness. Int J Mol Sci. 2021;22(21):11512.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"746_CR198","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14103","volume":"240","author":"H Shi","year":"2024","unstructured":"Shi H, et al. Exercise-inducible circulating extracellular vesicle irisin promotes browning and the thermogenic program in white adipose tissue. Acta Physiol (Oxf). 2024;240(3):e14103.","journal-title":"Acta Physiol (Oxf)"},{"key":"746_CR199","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jnutbio.2019.05.008","volume":"70","author":"VF Motta","year":"2019","unstructured":"Motta VF, et al. Browning is activated in the subcutaneous white adipose tissue of mice metabolically challenged with a high-fructose diet submitted to high-intensity interval training. J Nutr Biochem. 2019;70:164\u201373.","journal-title":"J Nutr Biochem"},{"issue":"6","key":"746_CR200","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41366-022-01086-3","volume":"46","author":"ILP Bonfante","year":"2022","unstructured":"Bonfante ILP, et al. Combined training increases thermogenic fat activity in patients with overweight and type 2 diabetes. Int J Obes (Lond). 2022;46(6):1145\u201354.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"746_CR201","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1038\/s41467-022-32502-x","volume":"13","author":"B Martinez-Tellez","year":"2022","unstructured":"Martinez-Tellez B, et al. No evidence of brown adipose tissue activation after 24 weeks of supervised exercise training in young sedentary adults in the ACTIBATE randomized controlled trial. Nat Commun. 2022;13(1):5259.","journal-title":"Nat Commun"},{"issue":"3","key":"746_CR202","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/osp4.330","volume":"5","author":"P Motiani","year":"2019","unstructured":"Motiani P, et al. Exercise training alters lipoprotein particles independent of brown adipose tissue metabolic activity. Obes Sci Pract. 2019;5(3):258\u201372.","journal-title":"Obes Sci Pract"},{"issue":"3","key":"746_CR203","first-page":"134","volume":"29","author":"M Xiao","year":"2023","unstructured":"Xiao M, Zhang Y, Xu X. Calorie restriction combined with high-intensity interval training promotes browning of white adipose tissue by activating the PPARgamma\/PGC-1alpha\/UCP1 pathway. Altern Ther Health Med. 2023;29(3):134\u20139.","journal-title":"Altern Ther Health Med"},{"issue":"7","key":"746_CR204","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1249\/MSS.0000000000003136","volume":"55","author":"S Kim","year":"2023","unstructured":"Kim S, et al. Contribution of high-intensity interval exercise in the fasted state to fat browning: potential roles of lactate and beta-hydroxybutyrate. Med Sci Sports Exerc. 2023;55(7):1160\u201371.","journal-title":"Med Sci Sports Exerc"},{"key":"746_CR205","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nut.2019.03.015","volume":"66","author":"B Liu","year":"2019","unstructured":"Liu B, et al. Intermittent fasting increases energy expenditure and promotes adipose tissue browning in mice. Nutrition. 2019;66:38\u201343.","journal-title":"Nutrition"},{"issue":"22","key":"746_CR206","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202400451","volume":"68","author":"S Lei","year":"2024","unstructured":"Lei S, et al. Intermittent fasting improves insulin resistance by modulating the gut microbiota and bile acid metabolism in diet-induced obesity. Mol Nutr Food Res. 2024;68(22):e2400451.","journal-title":"Mol Nutr Food Res"},{"issue":"14","key":"746_CR207","doi-asserted-by":"publisher","DOI":"10.3390\/nu17142331","volume":"17","author":"V Scoppola","year":"2025","unstructured":"Scoppola V, et al. Lifestyle intervention improves metabolic dysfunction-associated steatotic liver disease in children with Down syndrome. Nutrients. 2025;17(14):2331.","journal-title":"Nutrients"},{"issue":"1","key":"746_CR208","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/lsm.23839","volume":"57","author":"CRT Palauro","year":"2025","unstructured":"Palauro CRT, et al. Effects of cryolipolysis on the conversion of white adipose tissue: pilot study. Lasers Surg Med. 2025;57(1):88\u201395.","journal-title":"Lasers Surg Med"}],"container-title":["Current Obesity Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00746-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13679-026-00746-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00746-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:03:35Z","timestamp":1785549815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13679-026-00746-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":208,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1007\/s13679-026-00746-z","relation":{},"ISSN":["2162-4968"],"issn-type":[{"value":"2162-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human subjects performed by any of the authors.","order":1,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors read and approved the final version of the manuscript for publication.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"68"}}